PIWIL4 and acute myeloid leukemia: Gene expression analyses revealed that, given its high expression among cancers studied and consistent overexpression in most AML patients, PIWIL4 could be a potential vulnerability that could be exploited as a therapeutic target in AML (Bamezai et al., 2023).